Cefepime microbiology: Difference between revisions

Jump to navigation Jump to search
Abdurahman Khalil (talk | contribs)
No edit summary
Abdurahman Khalil (talk | contribs)
No edit summary
Line 18: Line 18:
*[[Streptococcus pneumoniae]]  
*[[Streptococcus pneumoniae]]  
*[[Streptococcus pyogenes]] (Lancefield’s Group A streptococci)  
*[[Streptococcus pyogenes]] (Lancefield’s Group A streptococci)  
*[[Viridans group streptococci]].
*[[Streptococcus viridans|Viridans group streptococci]].

Revision as of 16:01, 18 December 2013

Microbiology

Cefepime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefepime has a broad spectrum of in vitro activity that encompasses a wide range of Gram-positive and Gram-negative bacteria. Cefepime has a low affinity for chromosomally-encoded beta-lactamases. Cefepime is highly resistant to hydrolysis by most beta-lactamases and exhibits rapid penetration into Gram-negative bacterial cells. Within bacterial cells, the molecular targets of cefepime are the penicillin binding proteins (PBP).

Susceptible organisms

Aerobic Gram-Negative Microorganisms:

Aerobic Gram-Positive Microorganisms: